Dennis McLoughlin - Pacira BioSciences, Chief Commercial Officer
| PCRX Stock | USD 24.14 0.32 1.34% |
Executive
Mr. Dennis McLoughlin is Chief Commercial Officer of the company since August 2018. He previously served as our Senior Vice President, Alliance Management from June 2018 until August 2018, our Vice President, Alliance Management from May 2017 to June 2018, our Executive Director, Alliance Management from January 2017 until May 2017, and as an Area Sales Director from December 2013 until January 2017. Prior to joining Pacira, he was President of Remedy Group, a pharmaceutical outsourcing company, from November 2003 until January 2014 since 2018.
| Age | 58 |
| Tenure | 7 years |
| Address | 5401 West Kennedy Boulevard, Tampa, FL, United States, 33609 |
| Phone | 813 553 6680 |
| Web | https://www.pacira.com |
Pacira BioSciences, Management Efficiency
The company has return on total asset (ROA) of 0.039 % which means that it generated a profit of $0.039 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1208) %, meaning that it created substantial loss on money invested by shareholders. Pacira BioSciences,'s management efficiency ratios could be used to measure how well Pacira BioSciences, manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.09 in 2025. Return On Capital Employed is likely to drop to -0.06 in 2025. At this time, Pacira BioSciences,'s Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 241.3 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 414.1 M in 2025.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Anil Namboodiripad | Dr Reddys Laboratories | 54 | |
| Thomas Rowland | ANI Pharmaceuticals | 58 | |
| Willie MD | Intracellular Th | N/A | |
| Sandeep Poddar | Dr Reddys Laboratories | N/A | |
| Mary Fritz | Prestige Brand Holdings | N/A | |
| Bhethanabottla Phanimitra | Dr Reddys Laboratories | N/A | |
| Richard Johnson | Phibro Animal Health | 75 | |
| Sushrut Kulkarni | Dr Reddys Laboratories | 54 | |
| Thomas Fu | HUTCHMED DRC | N/A | |
| Chad Gassert | ANI Pharmaceuticals | 48 | |
| Natalie May | Incannex Healthcare Ltd | N/A | |
| Larry Miller | Phibro Animal Health | 61 | |
| YUGANDHAR PUVVALA | Dr Reddys Laboratories | 48 | |
| Vivek Mittal | Dr Reddys Laboratories | N/A | |
| MD FAAFP | Collegium Pharmaceutical | 63 | |
| Raymond Vre | Dr Reddys Laboratories | 52 | |
| Archana Bhaskar | Dr Reddys Laboratories | 53 | |
| Sauri Gudlavalleti | Dr Reddys Laboratories | 42 | |
| Michael PharmD | Intracellular Th | N/A | |
| Samuel Parisi | Alkermes Plc | 50 | |
| Sumera Hasham | Dr Reddys Laboratories | N/A | |
Management Performance
| Return On Equity | -0.12 | ||||
| Return On Asset | 0.039 |
Pacira BioSciences, Leadership Team
Elected by the shareholders, the Pacira BioSciences,'s board of directors comprises two types of representatives: Pacira BioSciences, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pacira. The board's role is to monitor Pacira BioSciences,'s management team and ensure that shareholders' interests are well served. Pacira BioSciences,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pacira BioSciences,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Richard Kahr, Vice Resources | ||
| Daryl Gaugler, Chief Officer | ||
| Charles Laranjeira, Chief Technical Officer | ||
| Christopher Young, Chief Officer | ||
| Shawn Cross, Chief Officer | ||
| JD Esq, Chief Secretary | ||
| DO Ellis, Chief Officer | ||
| III CPA, Chief Officer | ||
| Max Reinhardt, Pres World | ||
| Dennis McLoughlin, Chief Commercial Officer | ||
| David Stack, Chairman and CEO | ||
| Kristen JD, Chief Secretary | ||
| Roy MD, Chief Officer | ||
| Susan Mesco, IR Contact Officer | ||
| Jonathan MD, Chief Officer | ||
| Lauren Riker, Principal Finance | ||
| Frank Lee, CEO Director | ||
| Esq III, Chief Officer |
Pacira Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pacira BioSciences, a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.12 | ||||
| Return On Asset | 0.039 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 1.27 B | ||||
| Shares Outstanding | 46.28 M | ||||
| Shares Owned By Insiders | 3.18 % | ||||
| Shares Owned By Institutions | 96.82 % | ||||
| Number Of Shares Shorted | 5.3 M | ||||
| Price To Earning | 14.34 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Pacira Stock Analysis
When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.